1 Relevant Concepts of Pertuzumab 1.1 Indications for Pertuzumab 1.2 Development of Pertuzumab in China 1.3 Governmental Approval of Pertuzumab in China 1.4 The Impact of COVID-19 on Pertuzumab sales in China 2 Sales of Pertuzumab in China, 2019-2020 2.1 Sales Value of Pertuzumab 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Pertuzumab 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Pertuzumab by Dosage Form in China, 2019-2020 2.3.1 Injection 2.3.2 Analysis of Other Dosage Forms 3 Analysis of Major Pertuzumab Manufacturers in China, 2019-2020 3.1 Analysis of Market Share of Major Pertuzumab Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Roche Pharma (Schweiz) AG 3.2.1 Enterprise Profile 3.2.2 Sales of PERJETA (Roche Pharma (Schweiz) AG's Pertuzumab) in China 4 Prices of Pertuzumab for Different Manufacturers in China, 2020-2021 4.1 Roche Pharma (Schweiz) AG (PERJETA) 4.2 Analysis of Other Enterprises 5 Prospect of Chinese Pertuzumab drug Market, 2021-2025 5.1 Influential Factors of Chinese Pertuzumab Market Development 5.1.1 The Impact of COVID-19 on Chinese Pertuzumab Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Pertuzumab Injection Registration in China Chart Sales Value of Pertuzumab Injection over the World Chart Sales Value of Pertuzumab Injection in China, 2019-2020 Chart Sales Value of Pertuzumab Injection in China by Region, 2019-2020 Chart Sales Volume of Pertuzumab Injection in China, 2019-2020 Chart Sales Volume of Pertuzumab Injection in China by Region, 2019-2020 Chart Market Share by Sales Value of Top Pertuzumab Manufacturers in China, 2019-2020 Chart Sales Value and Volume of PERJETA in China, 2019-2020 Chart Referential Prices of PERJETA in China, 2020-2021 Chart Forecast on Sales Value of Pertuzumab in China, 2021-2025 Chart Forecast on Sales Volume of Pertuzumab in China, 2021-2025

Roche Pharma (Schweiz) AG